They are written by UK doctors and based on research evidence, UK and European Guidelines. You may find the Malaria article more useful, or one of our other health articles. Is plaquenil a biologic Plaquenil causing worse asthma problems Chloroquine is used for the prophylaxis of malaria in areas of the world where the risk of chloroquine-resistant falciparum malaria is still low. It is also used with proguanil when chloroquine-resistant falciparum malaria is present. However, this combination may not be ideal. Chloroquine works best when you take it on a regular schedule. For example, if you are taking it once a week to prevent malaria, it is best to take it on the same day of each week. Make sure that you do not miss any doses. If you have any questions about this, check with your doctor. ACT is currently the front-line treatment for Plasmodium falciparum malaria. If any parasites are left in the body after treatment, the disease may return. For example, Plasmodium vivax and Plasmodium ovale are able to lie dormant and hidden in the liver even if the parasite has been cleared from the rest of the body. These parasites, called plasmodia, belong to at least five species. Malaria is an infection caused by single-celled parasites that enter the blood through the bite of an Anopheles mosquito. Chloroquine dormant malaria Chloroquine Phosphate - WebMD, Chloroquine Oral Route Proper Use - Mayo Clinic Hydroxychloroquine sulfatelupusPlaquenil et allergie au soleilSide effect of hydroxychloroquine sulfateRheumatoid arthritis methotrexate therapy hydroxychloroquine monotherapyGeneric name of plaquenil High doses of chloroquine, such as those used to treat rheumatoid arthritis, have been associated with retinopathy; this serious side effect appears to be extremely unlikely when chloroquine is used for routine weekly malaria prophylaxis. Malaria - Chapter 4 - 2020 Yellow Book Travelers' Health CDC. How is malaria treated and prevented? Facts. Global extent of chloroquine-resistant Plasmodium vivax a systematic.. Chloroquine is the drug of choice for treating most patients with malaria caused by P. vivax, P. ovale, P. malariae and chloroquine-sensitive strains of P. falciparum. However, due to the development of resistance, chloroquine is ineffective against most strains of P. falciparum in South America, Africa and Asia. Chloroquine is the generic form of the brand-name prescription medicine Aralen, which is used to prevent and treat malaria — a mosquito-borne disease caused by a parasite — and to treat amebiasis, an infection of the intestines caused by a parasite. However, the most prevalent malaria parasite is P. vivax, which has a dormant liver form that can activate years after initial infection, causing a relapse of blood-stage disease. Dr. Kappe, the associate director of the Center for Global Infectious Disease Research, conducts fundamental and translational research to prevent and eliminate malaria.